The number of Atlanta Braves players on the injured list has reached double digits after two of their core players, starting pitcher Max Fried and second baseman Ozzie Albies, went down over the weekend. Fried had a 3.08 ERA/3.71 FIP across 108 innings for the Braves before landing on the IL with neuritis in his left forearm, which first flared up while he was warming up for his All-Star Game appearance. In Atlanta’s 6-2 loss to the Cardinals on Sunday, Albies broke his wrist when his glove hand collided with a sliding Michael Siani on a stolen base attempt; the second baseman is expected to be out for nearly the rest of the regular season.

To replace Fried and Albies on the roster, the Braves recalled lefty Dylan Dodd and shortstop Nacho Alvarez Jr. from Triple-A Gwinnett and signed veteran 2B/OF Whit Merrifield to a major league contract.

Ozzie Albies today underwent X-rays that revealed a left wrist fracture. He is expected to miss approximately eight weeks.

— Atlanta Braves (@Braves) July 21, 2024

After missing a good chunk of last year due to forearm pain, the 30-year-old Fried stumbled in his first two starts of this season but has been dominant since then. He’d also stayed healthy through the first half of the season, which was especially crucial for the Braves given the early-season loss of righty Spencer Strider to Tommy John surgery. The silver lining here – important since any mention of a pitcher’s having forearm pain justifiably will send fans into a panicked binge of one of their vices – is that there is no structural damage in his pitching arm and he will not require surgery. Instead, the Braves are choosing to be cautious with Fried because neuritis in the forearm can be related to an underlying problem with the UCL. Fried has already had Tommy John surgery once, about a decade ago when he was still a Padres prospect. Neither the Braves nor Fried have offered a timetable for his return, but Fried was optimistic that this would be a short-term issue. Per The Athletic’s David O’Brien:

“Everything structurally looks great, just a little irritated sensory nerve,” Fried said, “not one of the major muscle-functioning nerves. … Just going to let it calm down, and (I’m) hoping to be back soon.”

That there was no mention of ulnar nerve transposition surgery, which would have kept Fried out for months, has to be considered a good sign. Or, again, at least a less bad one.

After getting off to a hot start in April, Albies has struggled in recent months, and has hit just .235/.285/.376 since the end of April. He may be having arguably the worst year his career, but Atlanta was hopeful that he could return to form over the final two and a half months of the season. Losing even this lesser version of Albies lowers the ceiling of this underperforming offense, which ranks 11th among the 15 NL teams in runs scored.

Atlanta may be punchless, but it’s not witless – or should I say Whitless – as the team quickly signed Merrifield to a major league contract. Merrifield’s peak years with the Royals are long behind him at this point, and he was only available for the Braves because the Phillies released him over a week ago after he’d batted .199/.277/.295 (65 wRC+) across 174 plate appearances in a utility role. The projection systems are not bullish on Merrifield’s performance the rest of the season; Steamer expects Merrifield to post a .250/.303/.362 line over the final months of the year while ZiPS has him slightly worse, at .244/.293/.354. That said, the Braves simply don’t have any good in-house options to turn to instead. I ran the projections for every player at Triple-A or Double-A for Atlanta who has played at least three games at second base this year. I’m also including Alvarez, who has not played second base professionally but appears to be the frontrunner to replace Albies.

If ZiPS is correct, the Braves appear to have identified Alvarez as their best short-term option at second base, with Merrifield filling a utility role and serving as the best second-base Plan B.

The Phillies were already overwhelming favorites to win the NL East, with ZiPS giving them an 85% chance of taking the division as of this morning if Fried and Albies had been healthy. Assuming two missed months for Albies and an average of three weeks for Fried, ZiPS drops Atlanta’s chances of running down the Phillies from 14% to 6%. Fortunately, the Braves remain in a commanding position for one of the NL Wild Card spots. These two injuries only drop their playoff probability in ZiPS from 91% to 88%, so while unwelcome, they shouldn’t cause any premature towel-throwing.

In one last bit of looking on the bright side, Atlanta has a lot more options now than it would if these injuries happened in two weeks. We’re just over a week from the trade deadline, and there are a variety of second basemen and pitchers, of varying plausibility, available. A package that included a relief arm – Atlanta is deep here – could conceivably tempt the Orioles into parting with a prospect like Connor Norby. Amed Rosario of the Rays and Isiah Kiner-Falefa of the Blue Jays have both been solid this season. I’m not sure Atlanta could successfully trade its entire farm system and get Garrett Crochet or Tarik Skubal if it wanted to, but the price of Erick Fedde ought to be more reasonable. The Braves might choose to stick with what they have and muddle through, but it’s always nice to be able to make that choice.

It says a lot about the Braves that despite all of their nasty surprises this season, they remain on a pace to win 89 games and comfortably make the playoffs. But with these two latest injuries, the team’s margin for error has been cut thinner than a nice piece of charcuterie.

All-Star Week is the traditional midpoint of the baseball season — though not the mathematical one – and with the MLB Draft adding a bunch of new prospects to the minors, it’s a good time to look back at the ZiPS prospect list from this past winter. Some prospects have excelled in the majors and some, well, not so much, but that’s why we call them prospects and not certainties. Interpreting minor league statistics properly has always been a challenge, but it’s more so these days with an unusual divergence in offensive levels between the majors and high minors, especially the Triple-A leagues. An .850 OPS that may have been impressive in the International League a few years ago isn’t that mouth-watering these days, while an ERA around four is unusually promising. ZiPS, naturally, has to translate minor league performance as part of predicting how players will fare in the majors, and now that we have public Statcast data for the minors, there’s even more to dig into in 2024.

For each player in last winter’s ZiPS Top 100, I’m listing quick lines for their translated minor league performance (lower-case m), any major league performance, and lastly, a combination of the two to get one 2024 line (noted with a c).

As I’ve said before, Jackson Holliday might actually be underrated at this point. I got a lot of complaints about the “bearish” .255/.341/.381 projection for him coming into the season, but ZiPS (and I) shared the belief that people were coming too quickly on him. He’s still extremely likely to be a fantastic player, but considering he’s a 20-year-old who blasted through four levels of the minors, it’s not the weirdest thing ever that he’d see a consolidation season. That .336/.332 OBP/SLG isn’t really that far behind his projection, especially considering ZiPS expected the major league offensive environment to be better than it has been this season.

Coby Mayo has had the better season but still wouldn’t come close to passing Holliday if I rerolled the full top prospects right now. James Wood actually has surpassed Holliday, though that will only last until he exceeds the rookie maximum and sheds his prospect status; he was legitimately excellent in the minors this year. The sheen has come off both Wyatt Langford and Evan Carter a little bit, while Jackson Chourio and Masyn Winn have performed about as advertised. As movers go, Adael Amador and Pete Crow-Armstrong look like the two who will take the biggest hit of this group before next year’s rankings (if PCA hasn’t graduated). There hasn’t been as much ink about Emmanuel Rodriguez as I would have expected this year, even before he injured his thumb last month. The Texas League, unlike the Triple-A leagues, is a pretty low offensive environment, with a league OPS of just .705, so his actual 1.100 OPS is pretty impressive.

Yoshinobu Yamamoto and Shota Imanaga have both performed as well as ZiPS expected. While that’s hardly going out on a limb for Yamamoto, whom everyone liked, ZiPS was in on Imanaga very early. Paul Skenes, of course, has been fabulous, even more so than his top-notch translations from April and May. I’d only describe two of the pitchers on this list as unmitigated disappointments so far in 2024, at least from a projections standpoint: Both Ricky Tiedemann and Dylan Lesko will take pretty big hits in the next rankings. Andrew Painter will slide quite a bit as well, but it would be pretty churlish to call a pitcher a disappointment for being injured.

Among this tranche of prospects, Brooks Lee is having arguably the most impressive 2024, and he’s continued to hit since his call-up a couple of weeks ago. Between Lee and the Twins’ taking Kaelen Culpepper with their first-round pick on Sunday, Edouard Julien might get lost in the shuffle quickly in Minnesota; if I were a GM of a team in need of a second baseman, I’d give the Twins call to see if he can rule again on my club. Anyway, I actually expected ZiPS to come around quicker on Dylan Crews, but he’s not really torching minor league pitching as I thought he would. Davis Schneider has long been a ZiPS favorite, but he’s cooled off since a hot run right after he earned more playing time through the process of elimination in Toronto’s struggling lineup.

Jett Williams inevitably will drop considerably after a wrist injury ruined his 2024 season, and Kevin Alcantára was one of the big ZiPS droppers in terms of future WAR. While Samuel Basallo is not matching his breakout 2023 season, he’s still a 19-year-old catcher, so he won’t sag in the rankings too far.

Looking at this group’s long-term projections, it’s almost shocking how little movement there’s been in the long-term projections. Of these 21 pitchers, only three have had their five-year projected WAR move by more than two WAR. The first is Drew Thorpe, who was solid for Birmingham, and his poor K/BB ratios in the majors so far probably aren’t representative of his abilities. The other is a much less heralded prospect, Thomas Harrington of the Pirates, a rather Doug Fister-y prospect (is that a legal adjective), who relies on control and changeups. The high minors can be cruel for this type of pitcher, but he’s survived at least one of the jumps, to Double-A, which improves his long-term outlook. On the flip side, Mick Abel’s command has continued to deteriorate, with both a seven-walk and a six-walk outing in the last month. It would be a shock if he didn’t fall completely off the ZiPS Top 100 for 2025.

It hasn’t shown yet in the majors, but Kyle Manzardo’s minor league performance this year before his call-up wiped out the real “meh” feeling that ZiPS had about his 2023. Post-suspension Noelvi Marte has been pretty lousy, though we have enough data from players after drug suspensions to dismiss any histrionics that he’s struggled because of the lack of performance enhancement. Last year was largely the season that ZiPS came around on Colson Montgomery after being later than practically everyone/everything else, and the result has been a little how I feel after eating a hot dog from a gas station. Joey Ortiz is the big winner in this group, contending for the NL Rookie of the Year award, and Kyle Teel ought to see a bump in next year’s prospect rankings as well. Like Basallo, Ethan Salas’ bat has backslid a bit, but it’s not worth obsessing over how a teenage catching prospect is hitting. Andy Pages hasn’t matched his minor league start this year, but he’s been at least respectable.

Heston Kjerstad just missed the overall ZiPS gainers list, yet given Baltimore’s crowded offense, he’s still had trouble getting a full serving of plate appearances in the majors. If the O’s land Tarik Skubal or Garrett Crochet, Kjerstad has to be one of the names likely to be included, especially for the Tigers considering they are much more motivated to add major league-ready talent than the hopeless Sox. ZiPS was as big fan of Michael Busch, one of those low-ceiling, high-floor hitters without any real positional value, and he’s performed about as well for the Cubs as could have reasonably been expected.

ZiPS was hoping for more power from Matt Shaw, and he’ll probably drop from the top 100 unless his trajectory changes again. But he won’t drop as far as Luisangel Acuña, who has only a 73 wRC+ in Triple-A, though the Mets don’t actually seem disappointed with his performance. Even as offense is up across Triple-A, Angel Martínez was having a dynamite season before he was called up; you shouldn’t dismiss a 147 wRC+ at Triple-A without a pretty compelling reason. He’s also continued to hit in the majors, and I now feel kinda guilty that I didn’t give ZiPS some new RAM to reward it for being so high on him coming into the season.

The Texas Rangers came into the season with every intention of competing for another World Series championship. While the team had a fairly low-key winter, the ZiPS projection system thought it would be legitimately competitive in the AL West, though not necessarily one of baseball’s top teams. Instead, with less than half the season’s slate of games remaining, Texas sits uncomfortably below .500 with the playoff math looking increasingly daunting.

When the season began, my understanding was the Rangers expected to struggle at times during the first half, especially in the rotation, and they were OK with that as long as they didn’t fall too far behind the other AL West contenders, the Houston Astros and Seattle Mariners. The organization was comfortable letting Jordan Montgomery walk in free agency because it felt the team had enough punch in the lineup to remain in the division race long enough for at least some of its injured pitchers to get healthy and reinforce the roster, which would be as good as acquiring a starter in a deadline trade.

For about a month, this scenario seemed to be playing out. The Astros limped miserably out of the gate, and the Mariners didn’t do much better. The Rangers spent most of April leading the AL West, but they didn’t build enough of a cushion. That came back to bite them when Seattle caught fire and Houston turned its season around. Simultaneously, Texas went in the other direction. Since May 1, the Rangers offense has put up a 92 wRC+, and that’s with the benefit of Corey Seager mashing after his early slump (.286/.367/.563 in that span) and Wyatt Langford hitting way better since coming off the IL in late May (.285/.339/.464). With the 17th-ranked ERA and 24th-ranked FIP since the start of May, the pitching staff hasn’t exactly made up for the offensive shortfall.

As of Thursday morning, ZiPS has the Rangers with a 10% chance to make the playoffs, far short of their projected 56% odds coming into the season. The projections still see the AL West as a race, but mostly between the Astros and Mariners, with Texas assuming the role of the third-place underdog.

Of course, 10% isn’t zero, but the Rangers certainly have their work cut out for them. ZiPS currently assumes that, on average, the Rangers will be a .500 team the rest of the season. Let’s make a different assumption, that ZiPS is very wrong, and on average, they will be a .530 team from here on out. That still only boosts their playoff probability to 17.8%. Simply playing better is no longer enough, and there is unlikely to be any kind of reasonable deadline addition that would help them flip the script.

At the same time, Texas is still positioned well for a run in 2025, so there’s no need to blow the whole team up. Looking at just the main contributors under team control, ZiPS generally sees brighter days ahead next season.

ZiPS projects this group of players to win six or seven more games in 2025 than they’re projected to this season. (The win total for 2024 is a combination of the team’s season-to-date and rest-of season projections.) That’s an impressive number in most circumstances, but even more so for a rather old team; the offense is slightly older than league average and the pitching staff is the oldest in the majors. This group already has a good case for contention in 2025.

So if this year’s a longshot and 2025 looks better, what’s the winning argument for not retooling with a focus toward improving the roster for next season? That’s not rhetorical; I don’t have a good one (and feel free to make one in the comments that my cold-stricken brain couldn’t conjure). Again, the Rangers won the World Series last fall, and having that ring already earned ought to give the team some room to maneuver without angering the fanbase. Now, the Rangers won’t be able to snag prospects on the level of Jackson Holliday or James Wood for the players they’d be willing to trade, but in swaps for their players on expiring contracts — Max Scherzer, Nathan Eovaldi, David Robertson, Andrew Heaney, José Leclerc, Kirby Yates, and Michael Lorenzen — I would think they could at least get some talent that could help them in the future, even if you assume Scherzer sticks to his stated preference that he won’t waive his no-trade clause.

Dropping out of a race when you’re the defending champ is a tough thing to do psychologically. But the Rangers are in a bad place right now, and by throwing in the towel, they could improve their chances to contend for another title in 2025.

The 2020s have been a quiet time for the Boston Red Sox. Since winning the 2018 World Series, their fourth in a 15-year period, Boston hasn’t looked much like one of the titans, ready to throw down with the Yankees or Astros in brutal warfare for baseball supremacy. Instead, as an organization, the Red Sox have taken on the character of a genial, pastorale retiree, gently reclining on the porch of an American Craftsman house, as if they were in a 1980s lemonade commercial.

On Independence Day in 2022, Boston was second in the AL East with the junior circuit’s third-best record, but in the space of a month, it had lost Nathan Eovaldi, Garrett Whitlock, Michael Wacha, and Rich Hill to injuries. It was the prime time to make trades, but the Red Sox did basically nothing that would have helped them maintain their playoff relevance; their pitching staff’s 6.30 ERA for July dropped them below .500 by the time the Sox made their pointless acquisition of Eric Hosmer at the trade deadline. At last year’s deadline, when they were just 3.5 games out of the final wild card spot, they decided the day was intolerably hot and they were content to sip the last of their sweet tea as they watched and waited for the fireflies to come out at the dying of the day. Once again, Boston is in contention during trade season, a half-game up on the Royals for the last AL playoff spot, and it’s time for them to get up off the porch. Read the rest of this entry »

One of the most frequent questions I receive about ZiPS is folks wondering how the long-term projections for X hitter or Y pitcher have changed compared to what they were preseason. Since we’re right around the midpoint of the season, this is a good time to review just how the first half of the 2024 season has shifted expectations for individual players. The methodology I’m using is simple: comparing the current 2025-2029 WAR projections versus the 2025-2029 WAR projections as predicted at the start of the season. I’ve only included good prospects and players who are currently relevant to the majors (or injured) so we don’t get a bunch of random Double-A pitchers who are slightly more or less below replacement level than they used to be gumming things up. I’m also not including the pitchers who’d be on the list because of season-ending injuries; a list of 15 pitchers who have worse long-term outlooks because they’re out for the season with Tommy John surgery or thoracic outlet syndrome isn’t particularly interesting.

Since I’m such a cheerful and upbeat fellow, let’s start with the gainers. I’m also including each player’s updated top three comps, because comps are fun, even if the individual players listed don’t really mean a lot to the projection. At the very least, it contextualizes expectations in a non-WAR manner: Read the rest of this entry »

One of the most frequent questions I receive about ZiPS is folks wondering how the long-term projections for X hitter or Y pitcher have changed compared to what they were preseason. Since we’re right at the midpoint of the season, this is a good time to review just how the first half of the 2024 season has shifted expectations for individual players. The methodology I’m using is simple: comparing the current 2025-2029 WAR projections versus the 2025-2029 WAR projections as predicted at the start of the season. I’ve only included good prospects and players who are currently relevant to the majors (or injured) so we don’t get a bunch of random Double-A hitters who are slightly more or less below replacement level than they used to be gumming things up. I’ll tackle position players today, with pitchers to follow next week. Read the rest of this entry »

12:01

Dan Szymborski: It is time.  A time for chats.

12:02

Dan Szymborski: I think there’s something to that…if not for Cleveland.

12:02

Dan Szymborski: I think if you go all-in, you at least want to have a really good shot at the division

12:03

Dan Szymborski: and the second best record

12:03

Dan Szymborski: It becomes trickier when you’re mostly chasing a wild card

Read the rest of this entry »

At this time last year, the Phillies faced a good deal of long-term uncertainty about their rotation. Aaron Nola was a free agent after the season, Zack Wheeler would follow a year later, and the only pitcher with a guaranteed contract past the 2024 season was Taijuan Walker. This time around, their rotation once again leads the league in WAR, but much of that future angst has been alleviated. The Phillies re-signed Nola and extended Wheeler during the offseason, and now they’ve locked up left-hander Cristopher Sánchez, a 2023 sensation who has remained one this season, for at least four more years, with two club options that could keep him around the through 2030 season.

The 27-year-old Sánchez, whom the Phillies acquired in a trade with the Tampa Bay Rays for Curtis Mead back in 2019, has a 2.67 ERA/2.49 FIP over 15 starts this season. That’s good for 2.6 WAR, fourth best among National League pitchers. Sánchez will receive a guaranteed $22.5 million over the next four seasons, buying out all of his possible years of arbitration, plus a $2 million signing bonus. Not bad for someone who had just one full year of service time entering 2024. The two club options come with a $1 million buyout each for 2029 and ’30, bringing the minimum value of the deal to $22.5 million. If the Phillies pick up those two options, for $14 million and $15 million, respectively, and if Sánchez secures top-10 finishes in the Cy Young voting during those option years, his salaries could increase to $16 million for 2029 and $19 million for ’30. That puts the maximum total value of the extension at $56.5 million over six years.

If you didn’t see Sánchez coming, you’re definitely not alone. Mead went on to become one of Tampa Bay’s top prospects – he was still ranked fourth in the Rays’ system and 32nd overall in our preseason prospects rankings – while Sánchez came back from the COVID layoff struggling against Triple-A hitters. Changeup pitchers with command issues generally aren’t highly regarded, and neither Sánchez’s cup of coffee in 2021 nor his larger carafe in 2022 suggested a pitcher who would become a key part of a top rotation a year later. The Phillies certainly weren’t confident in him entering 2023; he had lost weight over the offseason, and the team intended to give him only a single spot start in April after a White Sox doubleheader messed up the rotation’s rest days. From a story from last August by Matt Gelb of The Athletic:

Rob Thomson was transparent with Sánchez: This was one start, and one start only. Sánchez, who had missed most of spring training with various injuries, later said he appreciated the manager’s honesty. He knew where he stood.

Before the call ended, Brian Kaplan had a question. He is the team’s assistant pitching coach and director of pitching development. The Phillies had outlined an offseason plan for Sánchez, a lanky lefty from the Dominican Republic, and it went haywire. Sánchez was supposed to add bulk. But a long illness sapped him of strength. He lost more than 15 pounds. It compromised him in the spring when he failed to make an impression while the Phillies scrambled to fill the back of their rotation.

In truth, Sánchez didn’t dominate for Lehigh Valley last year, either, but he did accomplish one goal the team set out for him; by the summer, he had gained 25 pounds. That coincided with a small window of opportunity to grab the fifth spot in the rotation. The Phillies had used Matt Strahm in the role early in the season, but they were worried about his innings count. Dylan Covey had gotten a couple starts but was bombed by the Braves in his most recent one, and Bailey Falter, who had been in the rotation earlier, was in the minors and out with a neck injury. So Sánchez got the nod on June 17 against the A’s; he went four scoreless innings and allowed one hit. His tumbling changeup — which looks like the world’s least erratic forkball — clicked, and he never gave the Phillies a reason to boot him from the rotation. Even the acquisition of Michael Lorenzen didn’t cost him his job. The Phillies happily went with a six-man rotation rather than deprive themselves of Sánchez’s services.

Over the first half of this season, Sánchez has proven that his performance last year was no fluke. He’s now been up for a full calendar year, throwing 175 1/3 innings with 157 strikeouts with a 3.08 ERA across 31 starts. He surely won’t continue his rate of home run avoidance (just one allowed this season), but even if his home run rate were to regress heavily toward the mean and cause his ERA to jump to the low 3.00s, he’d still worthy of his rotation spot.

So, what’s the projection look like? Suffice it to say, ZiPS was not very excited about him coming into 2023.

That’s not disastrous; with those numbers, he would’ve been a competent spot starter/long reliever. But it wasn’t even a shadow of what he’s accomplished in the last year. So let’s spin up his current, much sunnier projection. How sunny? Let’s just say Tom Glavine pops up in the top 10 on his comps list and leave it at that.

Most teams would be ecstatic to have this projection from their no. 2 starter. From your no. 4, this is like waking up one morning and finding out that your garden hose somehow makes its own IPA. Based on these numbers, ZiPS projects Sánchez to be worth $27.3 million over the four-year extension, making this a decent value from the point of view of the Phils. The deal becomes even better for Philadelphia when you look at the option years; ZiPS projects Sánchez’s value for 2029 and ’30 to be worth a combined $41 million in free agency, $11 million more than the base value of those years if the Phillies pick up his options.

That leaves Ranger Suárez as the only key member of the rotation who might not be around long term. He’s set to hit free agency after the 2025 season, and considering his excellence this year, he probably won’t come cheap if the Phillies try to extend him; a six-year deal would cost them $135 million, according to ZiPS. Having Sánchez around until the end of the decade at such a generous rate could provide Philadelphia the flexibility to dole out more money to keep Suárez.

Before we go, I’ve been looking for an excuse to project the Phillies rotation, so I’m not letting this opportunity slip away! Using the innings allocation in our depth charts, ZiPS currently projects Phillies starting pitchers to accumulate 8.6 more WAR over the rest of the season, which would give their starters a combined 22.7 WAR for the entire 2024 campaign. Here’s how that compares to the best starting staffs in the five-man rotation era, which I’m somewhat arbitrarily starting in 1980:

That’s quite rarified air. Based on these projections, the Phillies would finish the season with baseball’s best rotation in more than a decade, since the 2013 Tigers. And with the Sánchez extension coming on the heels of the deals for Nola and Wheeler, Philadelphia has the chance to keep this party going for several more years.

These are the saddest of possible words,
Bryant to Báez to Rizzo.
Seeing projected WAR cut into thirds,
Bryant to Báez to Rizzo.
Quickly declining in other team’s hats,
by plate discipline or by powerless bats,
concussions and sore backs turn comebacks to splats,
Bryant to Báez to Rizzo.

The 2016 season was one of the greatest in the history of the Chicago Cubs, a franchise that dates back to 1870, before the National League even existed. After winning the World Series and ending a championship drought that dated back to 1908, there were a lot of reasons to think this team would continue to make deep playoff runs for another five or six years. Sure, they had a fairly old starting rotation, with only Kyle Hendricks expected to stick around for a while, but the lineup looked like it was equipped for a long stretch of dominance. Addison Russell was 22, Javier Báez and Kyle Schwarber were each 23, Kris Bryant, Jorge Soler, and Willson Contreras were all 24, and Anthony Rizzo was still just 26. The team’s big free agent signing from the previous winter, Jason Heyward, didn’t have a good first season in Chicago, but at 26, a bounce-back campaign wasn’t out of the question. Still, this version of the Chicago Cubs would turn out to only have four postseason wins and a single playoff series win (the 2017 NLDS) left in them. What’s more, the three brightest stars in that constellation, Bryant, Báez, and Rizzo, were all traded at the 2021 deadline ahead of reaching free agency. Now, years later, each faces a very uncertain future. Read the rest of this entry »

After a year of caressing hopes for a triumphant return of José Abreu’s salad days, the Astros released the veteran first baseman on Friday, ending his disappointing tenure in Houston. It would be an understatement to say the 37-year-old Abreu struggled this season; across 35 games, he batted .124/.167/.195 with two home runs, for an wRC+ of 2 and a WAR that I won’t repeat due to the possibility of children reading. The Astros still owe Abreu a hair under $31 million of the three-year deal he signed soon after the 2022 season, though they’ll be on the hook for slightly less than that if another team signs him for the pro-rated league minimum.

If David Ortiz’s magnificent final season represents the optimal scenario for a beloved veteran slugger to reach retirement, then Abreu’s time with the Astros exemplifies the other far end of the spectrum. During his nine years with the White Sox, from 2014-22, Abreu was one of the most consistent sluggers in baseball, batting .292/.354/.506 with 243 home runs, a 133 wRC+, and 28.3 WAR. He had five 30-homer seasons, and that doesn’t include the shortened 2020 campaign, when he smacked 19 longballs, a full-season pace of 51, en route to winning the AL MVP award. With Chicago, he also earned AL Rookie of the Year honors (2014), made three All-Star teams (’14, ’18, ’19), and won three Silver Sluggers (’14, ’18, ’20). When he became a free agent after his age-35 season and the White Sox didn’t show much interest in bringing him back, Abreu quickly signed with the Astros, who had won the World Series a few weeks earlier.

It seemed like the ideal destination for his three-year autumnal epilogue. Houston wasn’t counting on him to be the centerpiece of the lineup; rather, his role would be to shore up first base and/or designated hitter for a few years and support stars like Kyle Tucker, Yordan Alvarez, Jose Altuve, and Alex Bregman. With the Astros coming off a 106-win season and a World Series championship, with many of their core players returning, it certainly appeared that his new team would provide Abreu a better chance to win a ring than he would’ve had with the clearly fading White Sox. To get an idea of what the reasonable expectations were for Abreu when he signed with Houston, let’s look at his three-year ZiPS projections heading into the 2023 season:

While ZiPS was skeptical that Abreu would be an everyday starter for all three years in Houston, it broadly thought he would be an adequate average-ish option for a year or two. Abreu got off to a wretched start last year, hitting .214/.262/.253 with no home runs through May 14 while starting 39 of the team’s first 40 games. As I wrote last April, there wasn’t even a hint that his struggles were a fluke; his plate discipline had deteriorated and his power evaporated like a puddle after a July thunderstorm in Texas.

There are some highly concerning issues in Abreu’s early-season profile this year that weren’t present in other early starts. When he struggles, he still generally hits the ball extremely hard. This year, his exit velocity has averaged 86.6 mph with an overall hard-hit rate of 36.7% — extremely low numbers for him. He was lousy last April, hitting .217/.308/.348, but he was still crushing pitches he connected with, resulting in a 94.6 mph average EV and a hard-hit rate of 59.6%. He also struggled in April 2021, hitting .213/.296/.394, but with a 92.1 mph EV and a 53.7% hard-hit rate — not quite as good as 2022, but worlds better than where those numbers currently stand. He got off to good starts in 2018 and ’19, so they’re not particularly helpful, and he crushed the ball in August of 2020 (I did not include any 2020 seasons in the April numbers, as the year was just too weird).

Abreu played somewhat better over the rest of the 2023 campaign, hitting .246/.309/.435 with 18 homers across 102 games and capping things off with four homers in the postseason. Rather than taking Abreu’s early-season woes as a warning that the end was near, the Astros proceeded to do very little to pick up another bat over the offseason; their biggest move to add some boom to the lineup came when they acquired Trey Cabbage from the Los Angeles Angels. Given Houston’s ALCS elimination at the hands of its cross-state rivals, the Texas Rangers, and its 90-72 record being its weakest since 2016, it’s hard to guess why the Astros took such a lackadaisical approach to a possible issue. Whether it has to do with the front office overhaul after James Click left is a topic for another day.

This season started off even worse for Abreu. He hit .111/.161/.123 with no homers, for an OPS (.284) that was even lower than the career OPS of Hall of Fame pitcher/extremely awkward hitter Randy Johnson (.305). His exit velocity numbers looked a lot like they did the previous April, and he failed to hit a single barrel. Things were so rough that Abreu agreed to be optioned to the minors to figure things out, leading to the rather odd sight of a former MVP debuting in the minors at age 37; he went straight to the majors 10 years ago after the White Sox signed him as an international free agent out of Cuba, and he never even played in the minors on an injury rehab assignment. Abreu did get back to Houston after a stint in Rookie-ball and a couple games with Triple-A Sugar Land, and he even hit two homers this month. But the writing was on the wall, and with the Mariners finally putting some space between them and the rest of the AL West, the Astros clearly could not afford to wait endlessly for another revival that may never come.

Over the short term, Jon Singleton is likely to continue to get the majority of the playing time at first base with Abreu out of the picture, but saying Singleton improves the team is damning with faint praise; while it was cool to see him come back to the majors after a decade away, he’s not really a productive major league bat. Singleton turns 33 later this year and is a .183/.294/.322 career hitter in the majors, with projections that rank from terrible (.214/.327/.388 in Steamer, .215/.324/.376 in ZiPS) to even more terrible (THE BAT at .193/.289/.343). Rookie Joey Loperfido would seem to be the obvious in-house solution to replace Abreu, but he’s primarily been an outfielder to this point and the organization hasn’t given him many starts at first base in Triple-A, which seems inconsistent with the idea that the Astros will offer him the next crack at the job. A big improvement here likely would require a larger trade, and I’m frankly not sure the decision-makers in Houston right now are equipped to move swiftly and deftly.

What’s next for Abreu? While the natural inclination would be a return to the White Sox, I think that would be a dreadful idea. Mal Tiempo doesn’t bring bad weather to opposing pitchers anymore, and I can’t help but feel that everything good he’ll be remembered for in Chicago is in the past. The Sox need to use their losing season more productively than a farewell tour for Abreu, and a bench bat with the Pale Hose won’t get Abreu one last run in the playoffs. Perhaps the Dodgers will sign him in July and he’ll slug .700 in 100 at-bats in a part-time role, because they’re the Dodgers.

A fun player for a long time and a great leader for the team and his city, Abreu’s almost certainly going to fall short of the Hall of Fame, perhaps even dropping off the ballot after his first year of eligibility. It would be shocking if he added much to his career 263 homers or 26.3 WAR (which is actually two wins less than it was when he left the White Sox), and we’ve yet to see the Hall of Fame voters credit foreign play to get a borderline player over the top. Ichiro Suzuki will easily make the Hall of Fame when he debuts on the ballot in the upcoming election, but that would be the case even if he had never played in Japan. I wrote a little about the possibility of including Abreu’s time in Cuba to evaluate his Hall of Fame case back in 2021, but that was more of a theoretical exercise than a serious expectation he’ll get votes.

No, Abreu is not going out on his best, but the cruelty of time in baseball isn’t that different from life. At some point, all of us will lose our ability to do the things we’re great at, the things we love, and eventually, anything at all. It’s just that as a ballplayer, his transition comes at a relatively younger age under very public scrutiny. I’ve always been a fan of the Orson Welles quote on the subject, and it’s one I’ve said that I’d like to have on my eventual epitaph: “If you want a happy ending, that depends, of course, on where you stop your story.” If this is the melancholy final chapter of the story of Abreu’s baseball career, it was still a volume that was wonderful to read.